Using Telemedicine to Monitor Diabetic Type 1 Patient
Student’s Name
Institutional Affiliation
Course
Instructor’s Name
Date
Using Telemedicine to Monitor Diabetic Type 1 Patient
Telemedicine is an essential technology that uses telecommunication to support the process of providing health care to a patient that is remotely located or those who may not regularly come physically for a check-up. It helps interpret patient progress data useful in providing preventive interventions (Hazenberg, et al., 2020). This technology will be crucial in creating a close relationship between a patient and health provider. With telemedicine, the patient’s treatment progress will be improved, reducing treatment expenses such as transport.
Following the medication plans of type 1 diabetic patients, the primary treatment involves insulin therapy, taking healthy diets, and carrying out regular exercise daily. Because of failure to adhere to these recommendations, the patient may develop serious complications such as Hypoglycaemia that develops as a result of too much insulin and diabetic ketoacidosis that occurs due to lack of adequate insulin (Miller, Costacou, & Orchard, 2019). Therefore the use of telemedicine would be appropriate in guiding the patient to fill the insulin medication. Because of fear of non-adherence to medication, a patient needs to be reminded and have a proper understanding of procedures such as injecting insulin, testing blood samples, type of food to eat. So telecommunication would ensure that the health provider assesses the progress of this patient daily, by interviewing the patient and taking notes on points that need further medical intervention.
Therefore, I plan to use this method because it would enable me to get reliable data from my diabetic patient. The telecommunication needs video communication such using zoom; hence I will be able to take note of visible symptoms, such as body changes. I will also be able to detect whether my patient is distress as this condition may introduce the risk factor of suffering other diseases.
References
Hazenberg, C. E., Aan de Stegge, W. B., Van Baal, S. G., Moll, F. L., & Bus, S. A. (2020). Telehealth and telemedicine applications for the diabetic foot: A systematic review. Diabetes/metabolism research and reviews, 36(3), e3247. https://doi.org/10.1002/dmrr.3247
Miller, R. G., Costacou, T., & Orchard, T. J. (2019). Risk factor modeling for cardiovascular disease in type 1 diabetes in the pittsburgh epidemiology of diabetes complications (EDC) study: a comparison with the diabetes control and complications trial/epidemiology of diabetes interventions and complications study (DCCT/EDIC). Diabetes, 68(2), 409-419. https://doi.org/10.2337/db18-0515